OrbiMed’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-58,800
| Closed | -$2.33M | – | 115 |
|
|
2023
Q4 | $2.33M | Buy |
+58,800
| New | +$2.33M | 0.05% | 93 |
|
|
2022
Q3 | – | Sell |
-112,700
| Closed | -$3.04K | – | 130 |
|
|
2022
Q2 | $3.04K | Sell |
112,700
-293,400
| -72% | -$7.91K | 0.06% | 118 |
|
|
2022
Q1 | $13.8M | Hold |
406,100
| – | – | 0.22% | 85 |
|
|
2021
Q4 | $15.7M | Sell |
406,100
-8,200
| -2% | -$317K | 0.2% | 97 |
|
|
2021
Q3 | $22.4M | Buy |
+414,300
| New | +$22.4M | 0.25% | 90 |
|
|
2020
Q4 | – | Sell |
-625,000
| Closed | -$9.27M | – | 151 |
|
|
2020
Q3 | $9.27M | Hold |
625,000
| – | – | 0.12% | 110 |
|
|
2020
Q2 | $8.13M | Buy |
+625,000
| New | +$8.13M | 0.11% | 107 |
|
|
2015
Q2 | – | Sell |
-40,000
| Closed | -$16.7M | – | 128 |
|
|
2015
Q1 | $16.7M | Sell |
40,000
-97,480
| -71% | -$40.8M | 0.14% | 82 |
|
|
2014
Q4 | $37.6M | Sell |
137,480
-7,960
| -5% | -$2.18M | 0.36% | 57 |
|
|
2014
Q3 | $28.3M | Hold |
145,440
| – | – | 0.3% | 58 |
|
|
2014
Q2 | $35.6M | Sell |
145,440
-11,067
| -7% | -$2.71M | 0.42% | 48 |
|
|
2014
Q1 | $41.5M | Buy |
156,507
+69,134
| +79% | +$18.3M | 0.51% | 45 |
|
|
2013
Q4 | $31.7M | Buy |
+87,373
| New | +$31.7M | 0.47% | 47 |
|